abstract |
The present invention relates to humain interleukin-3 (hIL-3)nvariant or mutant proteins (muteins) functionally co-administerednwith other colony stimulating factors (CSF),ncytokines, lymphokines, interleukins, hematopoietic growthnfactors or IL-3 variants. |